Answers are grounded in this paper and cite their sources.
Thiazolidinedione (TZD) is a privileged heterocyclic scaffold with significant importance in organic and medicinal chemistry due to its activated methylene group. It demonstrates a wide-ranging pharmacological potential. Over the past few decades, multicomponent reactions (MCRs) using thiazolidinedione have become efficient and versatile methods for the rapid synthesis of structurally diverse thiazolidinedione-based molecules. This work provides an overview of the latest research on thiazolidinedione as a key synthon in MCRs. It encompasses diverse properties, including nucleophilic, Michael donor, and dipolarophile, across various synthetic strategies. These methodologies have many merits, such as high atom economy, operational simplicity, short reaction time, and enhanced sustainability. They enable access to more structurally complex compounds with potentially interesting biological activities. The reaction design, mechanistic aspects, and catalytic systems are the key areas involved in the development of thiazolidinedione-based MCRs. In general, this study elucidates the synthetic and medicinal value of TZD chemistry in the synthesis of biologically relevant heterocyclic compounds.
No takes yet. Share an insight, caveat, or question.
Fatima et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: